Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Head and Neck Neoplasms 1Ependymoma 1Craniopharyngioma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 14Temozolomide 11Vincristine 9Magnetic Resonance Spectroscopy 9Cisplatin 9Etoposide 8Specimen Handling 7Radiotherapy 7X-Rays 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Lomustine 5Carboplatin 5Methotrexate 4Irinotecan 4Biopsy 4etoposide phosphate 3Thiotepa 3Radiation 3Platinum 3Nivolumab 3Filgrastim 3Celecoxib 3Bevacizumab 3Automobiles 31,2-diaminocyclohexaneplatinum II citrate 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Methionine × 1 year × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡